Literature DB >> 16676611

[Risk factors for dementia and Alzheimer' s disease-findings from a community-based cohort study in Stockholm, Sweden].

Cheng-xuan Qiu1, Bengt Winblad, Laura Fratiglioni.   

Abstract

OBJECTIVE: It is known that dementia is a multi-factorial disorder, but the etiological factors other than aging remain to be explored, hence we sought to investigate the risk factors of dementia and Alzheimer's disease (AD).
METHODS: We followed a community-based dementia-free cohort (n = 1301) aged 75 years and over in Stockholm, Sweden. Baseline data were obtained through a structured interview and extensive clinical examination, or by reviewing the inpatient register database. We used the DSM-III-R criteria to define dementia and AD cases.
RESULTS: Over six years of a follow-up program,350 subjects were diagnosed as dementia, including 260 Alzheimer cases. Multiple Cox regression analysis suggested that older age,low education (< 8 years), cognitive impairment, functional disability (ADL > or = 1), low diastolic pressure (< 70 mm Hg), diabetes mellitus, coronary heart disease, and APOEepsilon4 allele were significantly or marginally associated with subsequent development of dementia and AD. Dementia was related also to stroke and atrial fibrillation. Antihypertensive drug use was associated with a lower risk of AD and dementia.
CONCLUSIONS: Our study revealed that some sociodemographic features, cognitive and physical dysfunctions, vascular disorders, and genetic susceptibility were major risk factors for dementia and AD. Use of antihypertensive drugs might protect against the dementing disorders in a very old population.

Entities:  

Mesh:

Year:  2005        PMID: 16676611

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  7 in total

Review 1.  Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms.

Authors:  Gohar Mushtaq; Jalaluddin A Khan; Taha A Kumosani; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-05-23       Impact factor: 4.219

2.  Autoimmune autonomic ganglionopathy with reversible cognitive impairment.

Authors:  Christopher H Gibbons; Justin Centi; Steven Vernino; Roy Freeman
Journal:  Arch Neurol       Date:  2011-12-12

3.  Associations between coronary heart disease and risk of cognitive impairment: A meta-analysis.

Authors:  Xuan Liang; Yilin Huang; Xu Han
Journal:  Brain Behav       Date:  2021-03-20       Impact factor: 2.708

4.  Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?

Authors:  Gumpeny Ramachandra Sridhar; Hanuman Thota; Appa Rao Allam; Changalasetty Suresh Babu; Akula Siva Prasad; Ch Divakar
Journal:  Lipids Health Dis       Date:  2006-11-11       Impact factor: 3.876

5.  Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853).

Authors:  Arshi Naqvi; Anuja Pandey; Varsha Gupta; Richa Malasoni; Akansha Srivastava; Rishi Ranjan Pandey; M Satyanarayana; Ram Pratap; Anil Kumar Dwivedi
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

6.  Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease.

Authors:  Ramon Velazquez; Darren M Shaw; Antonella Caccamo; Salvatore Oddo
Journal:  Mol Neurodegener       Date:  2016-07-13       Impact factor: 14.195

7.  Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain).

Authors:  Manuel Fernández Martínez; Jessica Castro Flores; Susana Pérez de Las Heras; Aitziber Mandaluniz Lekumberri; María Gordejuela Menocal; Juan José Zarranz Imirizaldu
Journal:  BMC Neurol       Date:  2008-10-15       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.